乙型病毒性肝炎患者T淋巴细胞亚群及免疫因子变化研究

Hepatitis B viral hepatitis patients' peripheral blood T lymphocyte subsets and immune factor changes

  • 摘要: 目的 探讨乙型病毒性肝炎患者外周血T淋巴细胞亚群、干扰素-γ(IFN-γ)、肿瘤坏死因子-α(TNF-α)变化,分析免疫功能在疾病发展中的作用。方法 选取2013年1月-2015年1月诊治HBV感染的450例患者,并将作为HBV感染组,同期门诊体检健康人群100名为健康对照组,检测各组外周血T淋巴细胞亚群、IFN-γ、TNF-α变化,采用SPSS19.0软件进行统计分析。结果 HBV感染组外周血T淋巴细胞亚群低于健康对照组,HBV感染组IFN-γ、TNF-α高于健康对照组,差异有统计学意义(P<0.05);HBV-DNA阳性患者CD3、CD4、CD8、CD4/CD8低于阴性患者,IFN-γ高于阴性患者,差异有统计学意义(P<0.05);急性HBV感染患者CD8+、CD4+/CD8+比值低于慢性及隐匿性HBV感染患者,IFN-γ、TNF-α高于慢性及隐匿性HBV感染患者,差异有统计学意义(P<0.05);HBc-IgM阳性患者单纯保肝降酶治疗患者治疗6个月后CD3+、CD4+、IFN-γ、TNF-α低于加用IFN-α治疗患者,差异有统计学意义(P<0.05)。结论 乙型病毒性肝炎患者明显存在免疫功能紊乱,表现为外周血T淋巴细胞亚群、IFN-γ、TNF-α异常变化,而且对疾病转归存在一定影响。

     

    Abstract: OBJECTIVE To investigate the changes of peripheral blood T lymphocyte subsets, interferon gamma (IFN-γ), tumor necrosis factor alpha (TNF-α) of patients with hepatitis B viral (HBV) infection so as to analyze the immune function's role in the disease development. METHODS From Jan. 2013 to Jan. 2013, 450 patients with HBV infection were selected as study objects, and another 100 healthy people in the same period were chosen as control group. Changes of peripheral blood T lymphocyte subsets, IFN-γ and TNF -α levels were detected in the two groups. SPSS 19.0 was explored for statistical analysis. RESULTS T lymphocyte subsets in peripheral blood of HBV infection group were lower than that of the control group while IFN-γ and TNF-α levels were higher than those of the control group. The differences were significant (P<0.05).CD3, CD4, CD4/CD8 levels of HBV-DNA positive patients were lower than those with negative HBV-DNA, while IFN-γ level was higher. The differences were significant (P<0.05).Patients with acute HBV infection were proved to have lower CD8 level and CD4/CD8 ratio than patients with chronic and latent HBV infection, while IFN-γ and TNF-α levels were higher. The differences were significant (P<0.05). The CD3, CD4, IFN-γ and TNF-α levels of ,HBc-IgM positive patients after pure liver enzyme reduction treatment for 6 months were lower than patients treated with IFN-α. The differences were significant (P<0.05). CONCLUSION Hepatitis B patients have obvious immune function disorder, characterized by abnormal changes of peripheral blood T lymphocyte subsets, IFN-γand TNF-α and have a certain impact on disease outcome.

     

/

返回文章
返回